These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Severe cervical glandular cell lesions with coexisting squamous cell lesions. van Aspert-van Erp AJ, Smedts FM, Vooijs GP. Cancer; 2004 Aug 25; 102(4):218-27. PubMed ID: 15368313 [Abstract] [Full Text] [Related]
27. [Results of prospective cytological diagnoses of cervical intraepithelial neoplasia]. Saks A, Kodric T, Novak S, Vlaisavljević V. Jugosl Ginekol Opstet; 1983 Aug 25; 23(5-6):103-6. PubMed ID: 6678996 [Abstract] [Full Text] [Related]
28. Superficial endometriosis of the uterine cervix: a report of 20 cases of a process that may be confused with endocervical glandular dysplasia or adenocarcinoma in situ. Baker PM, Clement PB, Bell DA, Young RH. Int J Gynecol Pathol; 1999 Jul 25; 18(3):198-205. PubMed ID: 12090586 [Abstract] [Full Text] [Related]
29. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia. Liao SY, Stanbridge EJ. Cancer Epidemiol Biomarkers Prev; 1996 Jul 25; 5(7):549-57. PubMed ID: 8827360 [Abstract] [Full Text] [Related]
33. [Cytological classification of precancer and cancer of the cervix uteri]. Agamova KA, Nikitina NI, Gosh TE, Tikhomirova EE, Gladunova ZD. Vopr Onkol; 1987 Feb 25; 33(5):54-9. PubMed ID: 3590668 [Abstract] [Full Text] [Related]
35. [Cytologic charcteristics of histologic forms of cancer of the uterine cervix]. Botnar' ER. Arkh Patol; 1977 Feb 25; 39(3):56-63. PubMed ID: 871256 [Abstract] [Full Text] [Related]
36. A, B & H isoantigens in cervical lesions. Bisht D, Misra V, Gupta SC, Mehrotra R, Garg S. Indian J Pathol Microbiol; 1998 Jan 25; 41(1):11-4. PubMed ID: 9581070 [Abstract] [Full Text] [Related]
37. Histogenesis of cervical adenocarcinoma with reference to human papillomavirus-18 as a carcinogen. Okagaki T, Tase T, Twiggs LB, Carson LF. J Reprod Med; 1989 Sep 25; 34(9):639-44. PubMed ID: 2553963 [Abstract] [Full Text] [Related]
38. Benign to malignant progression in cervical squamous epithelium. Ehrmann RL. Compr Ther; 1996 Feb 25; 22(2):67-75. PubMed ID: 8689865 [No Abstract] [Full Text] [Related]
39. Management of adenocarcinoma in situ (ACIS) of the uteri cervix--a clinical dilemma. Tay EH, Yew WS, Ho TH. Singapore Med J; 1999 Jan 25; 40(1):36-9. PubMed ID: 10361484 [Abstract] [Full Text] [Related]
40. Estimation of the duration of the preclinical phase of cervical adenocarcinoma suggests that there is ample opportunity for screening. Plaxe SC, Saltzstein SL. Gynecol Oncol; 1999 Oct 25; 75(1):55-61. PubMed ID: 10502426 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]